Improvement of retroviral vectors by coating with poly(ethylene glycol)-poly(L-lysine) block copolymer (PEG-PLL)

✍ Scribed by Hiromichi Katakura; Atsushi Harada; Kazunori Kataoka; Miki Furusho; Fumihiro Tanaka; Hiromi Wada; Kazuhiro Ikenaka

• Publisher: John Wiley and Sons
• Year: 2004
• Tongue: English
• Weight: 178 KB
• Volume: 6
• Category: Article
• ISSN: 1099-498X
• DOI: 10.1002/jgm.519

✦ Synopsis

Abstract

Background

Although some cationic reagents, such as polybrene, improve gene transduction in vitro, their use in vivo is prohibited due to their toxicity to the exposed cells. This paper demonstrates that a new cationic reagent, poly(ethylene glycol)‐poly(L‐lysine) block copolymer (PEG‐PLL), improves gene transduction with retroviral vectors without increasing cell toxicity.

Methods

A retroviral vector derived from the Moloney leukemia virus, containing the __l__acZ gene, was modified with PEG‐PLL prior to transduction into NIH3T3, Lewis lung carcinoma, and primary cultured mouse brain cells. __Lac__Z transduction efficacy was evaluated by counting the number of X‐Gal‐positive cells.

Results

We have demonstrated that PEG‐PLL is able to stably modify the viral particle surface due to the affinity of the PEG moiety to the biomembrane, and neutralizes negative charges by the cationic nature of the poly‐lysine residue. Thus, PEG‐PLL increased the gene transduction efficiency and minimized cell toxicity because free PEG‐PLL was removable by centrifugation. We have shown that PEG‐PLL increased the viral gene transduction efficiency 3‐ to 7‐fold with NIH3T3 or Lewis lung carcinoma cell lines without increasing cytotoxicity. It improved retroviral gene transduction efficacy even against labile cells, such as primary cultured brain cells.

Conclusions

PEG‐PLL is a novel reagent that improves retroviral gene transduction efficacy without increasing cytotoxicity. Copyright © 2004 John Wiley & Sons, Ltd.